Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
An open-label, non-comparative, multi-centre, phase II prospective trial to assess the
efficacy of Quetiapine fumarate augmentation of selective serotonin reuptake inhibitors
(SSRIs) in SSRI-resistant major depressive disorder.